- Associations between different groups and characteristics of renal failure patients receiving hemodialysis.
| Variables | Positive (n=133) | Negative (n=34) | P-values |
|---|---|---|---|
| Gender | |||
| Male | 40 (81.6) | 9 (18.4) | 0.833 |
| Female | 93 (78.8) | 25 (21.2) | |
| Age group (years) | |||
| <19 | 4 (80.0) | 1 (20.0) | 0.842 |
| 20-40 | 39 (76.5) | 12 (23.5) | |
| 41-60 | 50 (83.3) | 10 (16.7) | |
| >60 | 40 (78.4) | 11 (21.6) | |
| Time of diagnosis with renal failure | |||
| Before vaccine was started | 93 (80.9) | 22 (19.1) | 0.542 |
| After vaccination was started | 40 (76.9) | 12 (23.1) | |
| Cause of renal failure | |||
| Diabetes | 47 (75.8) | 15 (24.2) | 0.890 |
| Hypertension | 25 (78.1) | 7 (21.9) | |
| Hereditary/congenital | 8 (88.9) | 1 (11.1) | |
| Other disease(s) | 15 (83.3) | 3 (16.7) | |
| Unknown | 38 (82.6) | 8 (17.4) | |
| Previous COVID-19 infection | |||
| No | 108 (81.8) | 24 (18.2) | 0.236 |
| Yes | 25 (71.4) | 10 (28.6) | |
| Type of vaccines received | |||
| Homogenous | 86 (77.5) | 25 (22.5) | 0.417 |
| Heterogeneous | 47 (83.9) | 9 (16.1) | |
| Number of doses | |||
| One | 0 (0.0) | 7 (100) | < 0.001* |
| 2 | 51 (77.3) | 15 (22.7) | |
| 3 | 82 (87.2) | 12 (12.8) | |
| Time since last dose | |||
| 10 weeks | 77 (84.5) | 14 (15.4) | 0.087 |
| 12 weeks | 56 (73.7) | 20 (26.3) | |
Values are presented as numbers and precentages (%).
↵* Significant at 95% confidence level. Data presented are obtained from Fisher’s exact test. COVID-19: coronavirus disease-19